agxАндрология и генитальная хирургияAndrology and Genital Surgery2070-97812412-890210.17650/2070-9781-2023-24-2-41-48agx-659Research ArticleОБЗОРНАЯ СТАТЬЯREVIEWНовые возможности клеточной и ударно-волновой терапии в восстановлении эректильной функции у пациентов, перенесших радикальную простатэктомию: обзор литературыNew possibilities of cell and shock wave therapy in erectile function recovery in patients after radical prostatectomy: a reviewhttps://orcid.org/0000-0002-8398-7255ЕпифановаМ. В.EpifanovaM. V.

Майя Владимировна Епифанова 

117198, Москва, ул. Миклухо-Маклая, д. 6, 

125284 Москва, 2-й Боткинский пр-д, 3

Maya V. Epifanova 

6 Miklukho-Maklaya St., Moscow, 117198, 

3 2nd Botkinskiy proezd, Moscow, 117198

 

epifanova_maya@mail.ruhttps://orcid.org/0000-0002-0792-6012КостинА. А.KostinA. A.

117198, Москва, ул. Миклухо-Маклая, д. 6

6 Miklukho-Maklaya St., Moscow, 117198

https://orcid.org/0000-0002-8509-4338ГамееваЕ. В.GameevaE. V.

117198, Москва, ул. Миклухо-Маклая, д. 6, 

125284 Москва, 2-й Боткинский пр-д, 3

6 Miklukho-Maklaya St., Moscow, 117198,

3 2nd Botkinskiy proezd, Moscow, 117198

 

https://orcid.org/0000-0002-5160-925XГрицкевичА. А.GritskevichA. A.

117198, Москва, ул. Миклухо-Маклая, д. 6,

117997 Москва, ул. Большая Серпуховская, 27

6 Miklukho-Maklaya St., Moscow, 117198,

27 Bolshaya Serpukhovskaya St., Moscow, 117997

https://orcid.org/0000-0002-3630-9427АртеменкоC. А.ArtemenkoS. A.

117198, Москва, ул. Миклухо-Маклая, д. 6

6 Miklukho-Maklaya St., Moscow, 117198

https://orcid.org/0000-0003-4111-6037ЕпифановА. А.EpifanovA. A.

127473 Москва, ул. Делегатская, 20, стр. 1

Bld. 1, 20 Delegatskaya St., Moscow 127473

Российский университет дружбы народов;РоссияRUDN University;Russian FederationРоссийский университет дружбы народовРоссияRUDN UniversityRussian FederationРоссийский университет дружбы народов; ФГБУ «Национальный медицинский исследовательский центр хирургии им. А.В. Вишневского» Минздрава РоссииРоссияRUDN University; A..V. Vishnevsky National Medical Research Center of Surgery, Ministry of Health of RussiaRussian FederationФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава РоссииРоссияA.I. Yevdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of RussiaRussian Federation2023200620232424148Copyright © Епифанова М.В., Костин А.А., Гамеева Е.В., Грицкевич А.А., Артеменко C.А., Епифанов А.А., 20232023Епифанова М.В., Костин А.А., Гамеева Е.В., Грицкевич А.А., Артеменко C.А., Епифанов А.А.Epifanova M.V., Kostin A.A., Gameeva E.V., Gritskevich A.A., Artemenko S.A., Epifanov A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://agx.elpub.ru/jour/article/view/659

В 2021 г. в западных странах рак предстательной железы впервые занял 1-е место среди других онкологических заболеваний по числу выявленных новых случаев. Радикальная простатэктомия до сих пор является методом выбора в целях радикальной терапии рака предстательной железы. Важной нерешенной проблемой остается реабилитация данной популяции мужчин, так как у подавляющего числа пациентов в послеоперационном периоде развиваются сексуальная дисфункция и расстройства мочеиспускания, что значительно снижает качество жизни. Это обстоятельство обусловливает актуальность поиска и разработки новых подходов к восстановлению эректильной функции после радикальной простатэктомии. В данном обзоре литературы представлены результаты поиска публикаций в российских и международных базах данных по вопросам лечения эректильной дисфункции после радикальной простатэктомии с помощью аутоплазмы, обогащенной тромбоцитарными факторами роста, и экстракорпоральной ударно-волновой терапии.

For the first time in 2021, prostate cancer took 1st place among other oncological diseases in Western countries. Radical prostatectomy is still the method of choice among the prostate cancer radical therapy. An important unresolved problem remains the rehabilitation, since the overwhelming number of patients in the postoperative period develop sexual dysfunction, urination disorders, which significantly reduces the quality of life. Thus, this condition actualizes the search and development of new approaches to the therapy of erectile function after radical prostatectomy. This literature review presents the results of a literary search of Russian and international databases on the erectile function recovery after radical prostatectomy using platelet rich plasma and extracorporeal shock wave therapy.

рак предстательной железыэректильная дисфункцияреабилитациярадикальная простатэктомияаутоплазмаобогащенная тромбоцитарными факторами ростаэкстракорпоральная ударно-волновая терапияprostate cancererectile dysfunctionrehabilitationradical prostatectomyplatelet rich plasmaextracorporeal shock wave therapyReferencesSung H., Ferlay J., Siegel R.L. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71(3):209– 49. DOI: 10.3322/caac.21660Sung H., Ferlay J., Siegel R.L. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71(3):209– 49. DOI: 10.3322/caac.21660Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer statistics, 2021. CA Cancer J Clin 2021:71(1):7–33. DOI: 10.3322/caac.21654Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer statistics, 2021. CA Cancer J Clin 2021:71(1):7–33. DOI: 10.3322/caac.21654Simone G. The epidemiology of prostate cancer. In: Prostate Cancer. Ed. by S.R.J. Bott, K.L. Ng. Australia, Brisbane: Exon Publications, 2021. 158 p.Simone G. The epidemiology of prostate cancer. In: Prostate Cancer. Ed. by S.R.J. Bott, K.L. Ng. Australia, Brisbane: Exon Publications, 2021. 158 p.Злокачественные новообразования в России в 2020 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2021. 252 с.Malignant tumors in Russia in 2020 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiology” Minzdrava Rossii, 2021. 252 p. (In Russ.).EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2022.EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2022.Haahr M.K., Jensen C.H., Toyserkani N.M. et al. Safety and potential effect of a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label phase I clinical trial. EBioMedicine 2016;5:204–10. DOI: 10.1016/j.ebiom.2016.01.024Haahr M.K., Jensen C.H., Toyserkani N.M. et al. Safety and potential effect of a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label phase I clinical trial. EBioMedicine 2016;5:204–10. DOI: 10.1016/j.ebiom.2016.01.024Huri M., Akel B.S., Sahin S. Rehabilitation of patients with prostate cancer. In: Prostate cancer – leading-edge diagnostic procedures and treatments. Ed. by R. Mohan. London: IntechOpen, 2016. Pp. 227–248. DOI: 10.5772/63989Huri M., Akel B.S., Sahin S. Rehabilitation of patients with prostate cancer. In: Prostate cancer – leading-edge diagnostic procedures and treatments. Ed. by R. Mohan. London: IntechOpen, 2016. Pp. 227–248. DOI: 10.5772/63989Ladegaard P.B.J., Mortensen J., Skov-Jeppesen S.M., Lund L. Erectile dysfunction a prospective randomized placebo-controlled study evaluating the effect of low-intensity extracorporeal shockwave therapy (LI-ESWT) in men with erectile dysfunction following radical prostatectomy. Sex Med 2021;9(3):100338. DOI: 10.1016/j.esxm.2021.100338Ladegaard P.B.J., Mortensen J., Skov-Jeppesen S.M., Lund L. Erectile dysfunction a prospective randomized placebo-controlled study evaluating the effect of low-intensity extracorporeal shockwave therapy (LI-ESWT) in men with erectile dysfunction following radical prostatectomy. Sex Med 2021;9(3):100338. DOI: 10.1016/j.esxm.2021.100338Avulova S., Zhao Z., Lee D. et al. The effect of nerve sparing status on sexual and urinary function: 3-year results from the CEASAR study. J Urol 2018;199(5):1202–9. DOI: 10.1016/j.juro.2017.12.037Avulova S., Zhao Z., Lee D. et al. The effect of nerve sparing status on sexual and urinary function: 3-year results from the CEASAR study. J Urol 2018;199(5):1202–9. DOI: 10.1016/j.juro.2017.12.037Ko Y.H., Coelho R.F., Sivaraman A. et al. Retrograde versus antegrade nerve sparing during robot-assisted radical prostatectomy: which is better for achieving early functional recovery? Eur Urol 2013;63(1):169–77. DOI: 10.1016/j.eururo.2012.09.051Ko Y.H., Coelho R.F., Sivaraman A. et al. Retrograde versus antegrade nerve sparing during robot-assisted radical prostatectomy: which is better for achieving early functional recovery? Eur Urol 2013;63(1):169–77. DOI: 10.1016/j.eururo.2012.09.051Alemozaffar M., Duclos A., Hevelone N.D. et al. Technical refinement and learning curve for attenuating neurapraxia during robotic-assisted radical prostatectomy to improve sexual function. Eur Urol 2012;61(6):1222–8. DOI: 10.1016/j.eururo.2012.02.053Alemozaffar M., Duclos A., Hevelone N.D. et al. Technical refinement and learning curve for attenuating neurapraxia during robotic-assisted radical prostatectomy to improve sexual function. Eur Urol 2012;61(6):1222–8. DOI: 10.1016/j.eururo.2012.02.053Шпоть Е.В., Чиненов Д.В., Чернов Я.Н. и др. Сравнительные результаты нервосберегающей робот-ассистированной простатэктомии. Андрология и генитальная хирургия 2021;22(3):44–8. DOI: 10.17650/1726-9784-2021-22-3-44-48.Shpot’ E.V., Chinenov D.V., Chernov Y.N. et al. Comparative results of nerve-sparing robotic-assisted prostatectomy. Andrologiya i genital’naya khirurgiya = Andrology and Genital Surgery 2021;22(3):44–8. (In Russ.). DOI: 10.17650/1726-9784-2021-22- 3-44-48Emanu J.C., Avildsen I.K., Nelson C.J. Erectile dysfunction after radical prostatectomy: prevalence, medical treatments, and psychosocial interventions. Curr Opin Support Palliat Care 2016;10(1):102–7. DOI: 10.1097/SPC.0000000000000195Emanu J.C., Avildsen I.K., Nelson C.J. Erectile dysfunction after radical prostatectomy: prevalence, medical treatments, and psychosocial interventions. Curr Opin Support Palliat Care 2016;10(1):102–7. DOI: 10.1097/SPC.0000000000000195Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 2005;6(11):889–98. DOI: 10.1038/nrn1788Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 2005;6(11):889–98. DOI: 10.1038/nrn1788Whalen M. Preventing erectile dysfunction after radical prostatectomy: nerve-sparing techniques, penile rehabilitation, and novel regenerative therapies. In: Prostatectomy. Ed. by T. Genadiev. London: IntechOpen, 2019. Pp. 129–174.Whalen M. Preventing erectile dysfunction after radical prostatectomy: nerve-sparing techniques, penile rehabilitation, and novel regenerative therapies. In: Prostatectomy. Ed. by T. Genadiev. London: IntechOpen, 2019. Pp. 129–174.Bratu O., Oprea I., Marcu D. et al. Erectile dysfunction postradical prostatectomy – a challenge for both patient and physician. J Med Life 2017;10(1):13–18. PMID: 28255370.Bratu O., Oprea I., Marcu D. et al. Erectile dysfunction postradical prostatectomy – a challenge for both patient and physician. J Med Life 2017;10(1):13–18. PMID: 28255370.Wang L., Sanford M.T., Xin Z. et al. Role of Schwann cells in the regeneration of penile and peripheral nerves. Asian J Androl 2015;17(5):776–82. DOI: 10.4103/1008-682X.154306Wang L., Sanford M.T., Xin Z. et al. Role of Schwann cells in the regeneration of penile and peripheral nerves. Asian J Androl 2015;17(5):776–82. DOI: 10.4103/1008-682X.154306Lagoda G., Sezen S.F., Burnett A.L. FK506 and rapamycin neuroprotect erection and involve different immunophilins in a rat model of cavernous nerve injury. J Sex Med 2009;6(7):1914–23. DOI: 10.1111/j.1743-6109.2009.01293.xLagoda G., Sezen S.F., Burnett A.L. FK506 and rapamycin neuroprotect erection and involve different immunophilins in a rat model of cavernous nerve injury. J Sex Med 2009;6(7):1914–23. DOI: 10.1111/j.1743-6109.2009.01293.xLeungwattanakij S., Bivalacqua T.J., Usta M.F. et al. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 2003;24(2):239–45. DOI: 10.1002/j.1939-4640.2003.tb02668.xLeungwattanakij S., Bivalacqua T.J., Usta M.F. et al. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 2003;24(2):239–45. DOI: 10.1002/j.1939-4640.2003.tb02668.xCui Y., Liu X., Shi L., Gao Z. Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Andrologia 2016;48(1):20–8. DOI: 10.1111/and.12405Cui Y., Liu X., Shi L., Gao Z. Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Andrologia 2016;48(1):20–8. DOI: 10.1111/and.12405Hamilton Z., Mirza M. Post-prostatectomy erectile dysfunction: contemporary approaches from a US perspective. Res Rep Urol 2014;6:35–41. DOI: 10.2147/RRU.S39560Hamilton Z., Mirza M. Post-prostatectomy erectile dysfunction: contemporary approaches from a US perspective. Res Rep Urol 2014;6:35–41. DOI: 10.2147/RRU.S39560Hebert K.J., Kohler T.S. Glans ischemia following inflatable penile prosthesis surgery. Transl Androl Urol 2020;9(2):824–7. DOI: 10.21037/tau.2020.01.04Hebert K.J., Kohler T.S. Glans ischemia following inflatable penile prosthesis surgery. Transl Androl Urol 2020;9(2):824–7. DOI: 10.21037/tau.2020.01.04Lokeshwar S.D., Patel P., Shah S.M., Ramasamy R. A systematic review of human trials using stem cell therapy for erectile dysfunction. Sex Med Rev 2020;8(1):122–30. DOI: 10.1016/j.sxmr.2019.08.003Lokeshwar S.D., Patel P., Shah S.M., Ramasamy R. A systematic review of human trials using stem cell therapy for erectile dysfunction. Sex Med Rev 2020;8(1):122–30. DOI: 10.1016/j.sxmr.2019.08.003Epifanova M.V., Gvasalia B.R., Durashov M.A., Artemenko S.A. Platelet-rich plasma therapy for male sexual dysfunction: myth or reality? Sex Med Rev 2020;8(1):106–13. DOI: 10.1016/j.sxmr.2019.02.002Epifanova M.V., Gvasalia B.R., Durashov M.A., Artemenko S.A. Platelet-rich plasma therapy for male sexual dysfunction: myth or reality? Sex Med Rev 2020;8(1):106–13. DOI: 10.1016/j.sxmr.2019.02.002EAU Guidelines. Edn. presented at the EAU Annual Congress Milan, 2021.EAU Guidelines. Edn. presented at the EAU Annual Congress Milan, 2021.Yao H., Wang X., Liu H. et al. Systematic review and meta-analysis of 16 randomized controlled trials of clinical outcomes of lowintensity extracorporeal shock wave therapy in treating erectile dysfunction. Am J Mens Health 2022;16(2):15579883221087532. DOI: 10.1177/15579883221087532Yao H., Wang X., Liu H. et al. Systematic review and meta-analysis of 16 randomized controlled trials of clinical outcomes of lowintensity extracorporeal shock wave therapy in treating erectile dysfunction. Am J Mens Health 2022;16(2):15579883221087532. DOI: 10.1177/15579883221087532Епифанова М.В. Применение аутоплазмы, обогащенной тромбоцитарными факторами роста, в лечении эректильной дисфункции. Дис. … канд. мед. наук. М., 2016. 167 с.Epifanova M.V. The use of autoplasm enriched with platelet growth factors in the treatment of erectile dysfunction. Dis. … candidate of medical sciences. Moscow, 2016. 167 p. (In Russ.).Епифанова М.В. Применение технологий регенеративной медицины при сексуальной дисфункции и нарушении фертильности у мужчин. Дис. … д-ра. мед. наук. М., 2022. 400 с.Epifanova M.V. The use of regenerative medicine technologies for sexual dysfunction and fertility disorders in men. Dis. ... doctor of medical sciences. Moscow, 2022. 400 p. (In Russ.).Lee J.W., Kwon O.H., Kim T.K. et al. Platelet-rich plasma: quantitative assessment of growth factor levels and comparative analysis of activated and inactivated groups. Arch Plast Surg 2013;40(5):530–5. DOI: 10.5999/aps.2013.40.5.530Lee J.W., Kwon O.H., Kim T.K. et al. Platelet-rich plasma: quantitative assessment of growth factor levels and comparative analysis of activated and inactivated groups. Arch Plast Surg 2013;40(5):530–5. DOI: 10.5999/aps.2013.40.5.530Nishio H., Saita Y., Kobayashi Y. et al. Platelet-rich plasma promotes recruitment of macrophages in the process of tendon healing. Regen Ther 2020;14:262–70. DOI: 10.1016/j.reth.2020.03.009Nishio H., Saita Y., Kobayashi Y. et al. Platelet-rich plasma promotes recruitment of macrophages in the process of tendon healing. Regen Ther 2020;14:262–70. DOI: 10.1016/j.reth.2020.03.009Wang Z., Mudalal M., Sun Y. et al. The effects of leukocyte-platelet rich fibrin (L-PRF) on suppression of the expressions of the proinflammatory cytokines, and proliferation of Schwann cell, and neurotrophic factors. Sci Rep 2020;10(1):2421. DOI: 10.1038/s41598-020-59319-2Wang Z., Mudalal M., Sun Y. et al. The effects of leukocyte-platelet rich fibrin (L-PRF) on suppression of the expressions of the proinflammatory cytokines, and proliferation of Schwann cell, and neurotrophic factors. Sci Rep 2020;10(1):2421. DOI: 10.1038/s41598-020-59319-2Pereira C.T., Paxton Z.J., Li A.I. Involvement of PDGF-BB and IGF-1 in activation of human Schwann cells by platelet-rich plasma. Plast Reconstr Surg 2020;146(6):825e–7e. DOI: 10.1097/PRS.0000000000007406Pereira C.T., Paxton Z.J., Li A.I. Involvement of PDGF-BB and IGF-1 in activation of human Schwann cells by platelet-rich plasma. Plast Reconstr Surg 2020;146(6):825e–7e. DOI: 10.1097/PRS.0000000000007406Zheng C., Zhu Q., Liu X. et al. Effect of platelet-rich plasma (PRP) concentration on proliferation, neurotrophic function and migration of Schwann cells in vitro. J Tissue Eng Regen Med 2016;10(5):428–36. DOI: 10.1002/term.1756Zheng C., Zhu Q., Liu X. et al. Effect of platelet-rich plasma (PRP) concentration on proliferation, neurotrophic function and migration of Schwann cells in vitro. J Tissue Eng Regen Med 2016;10(5):428–36. DOI: 10.1002/term.1756Pelletier J., Roudier E., Abraham P. et al. VEGF-A promotes both pro-angiogenic and neurotrophic capacities for nerve recovery after compressive neuropathy in rats. Mol Neurobiol 2015;51(1):240–51. DOI: 10.1007/s12035-014-8754-1Pelletier J., Roudier E., Abraham P. et al. VEGF-A promotes both pro-angiogenic and neurotrophic capacities for nerve recovery after compressive neuropathy in rats. Mol Neurobiol 2015;51(1):240–51. DOI: 10.1007/s12035-014-8754-1Hatanaka K., Ito K., Shindo T. et al. Molecular mechanisms of the angiogenic effects of low-energy shock wave therapy: roles of mechanotransduction. Am J Physiol Cell Physiol 2016;311(3):C378–85. DOI: 10.1152/ajpcell.00152.2016Hatanaka K., Ito K., Shindo T. et al. Molecular mechanisms of the angiogenic effects of low-energy shock wave therapy: roles of mechanotransduction. Am J Physiol Cell Physiol 2016;311(3):C378–85. DOI: 10.1152/ajpcell.00152.2016Pan M.M., Raees A., Kovac J.R. Low-intensity extracorporeal shock wave as a novel treatment for erectile dysfunction. Am J Mens Health 2016;10(2):146–8. DOI: 10.1177/1557988315574511Pan M.M., Raees A., Kovac J.R. Low-intensity extracorporeal shock wave as a novel treatment for erectile dysfunction. Am J Mens Health 2016;10(2):146–8. DOI: 10.1177/1557988315574511Yahata K., Kanno H., Ozawa H. et al. Low-energy extracorporeal shock wave therapy for promotion of vascular endothelial growth factor expression and angiogenesis and improvement of locomotor and sensory functions after spinal cord injury. J Neurosurg Spine 2016;25(6):745–5. DOI: 10.3171/2016.4.SPINE15923Yahata K., Kanno H., Ozawa H. et al. Low-energy extracorporeal shock wave therapy for promotion of vascular endothelial growth factor expression and angiogenesis and improvement of locomotor and sensory functions after spinal cord injury. J Neurosurg Spine 2016;25(6):745–5. DOI: 10.3171/2016.4.SPINE15923Jeong H.C., Bae W.J., Zhu G.Q. et al. Synergistic effects of extracorporeal shockwave therapy and modified Ojayeonjonghwan on erectile dysfunction in an animal model of diabetes. Investig Clin Urol 2019;60(4):285–94. DOI: 10.4111/icu.2019.60.4.285Jeong H.C., Bae W.J., Zhu G.Q. et al. Synergistic effects of extracorporeal shockwave therapy and modified Ojayeonjonghwan on erectile dysfunction in an animal model of diabetes. Investig Clin Urol 2019;60(4):285–94. DOI: 10.4111/icu.2019.60.4.285Jeon S.H., Shrestha K.R., Kim R.Y. et al. Combination therapy using human adipose-derived stem cells on the cavernous nerve and low-energy shockwaves on the corpus cavernosum in a rat model of post-prostatectomy erectile dysfunction. Urology 2016;88:226.e1–9. DOI: 10.1016/j.urology.2015.10.021Jeon S.H., Shrestha K.R., Kim R.Y. et al. Combination therapy using human adipose-derived stem cells on the cavernous nerve and low-energy shockwaves on the corpus cavernosum in a rat model of post-prostatectomy erectile dysfunction. Urology 2016;88:226.e1–9. DOI: 10.1016/j.urology.2015.10.021Lin G., Reed-Maldonado A.B., Wang B. et al. In situ activation of penile progenitor cells with low-intensity extracorporeal shockwave therapy. J Sex Med 2017;14(4):493–501. DOI: 10.1016/j.jsxm.2017.02.004Lin G., Reed-Maldonado A.B., Wang B. et al. In situ activation of penile progenitor cells with low-intensity extracorporeal shockwave therapy. J Sex Med 2017;14(4):493–501. DOI: 10.1016/j.jsxm.2017.02.004Patel A.N., Selzman C.H., Kumpati G.S. et al. Evaluation of autologous platelet rich plasma for cardiac surgery: outcome analysis of 2000 patients. J Cardiothorac Surg 2016;11(1):62. DOI: 10.1186/s13019-016-0452-9Patel A.N., Selzman C.H., Kumpati G.S. et al. Evaluation of autologous platelet rich plasma for cardiac surgery: outcome analysis of 2000 patients. J Cardiothorac Surg 2016;11(1):62. DOI: 10.1186/s13019-016-0452-9Gentile P., Di Pasquali C., Bocchini I. et al. Breast reconstruction with autologous fat graft mixed with platelet-rich plasma. Surg Innov 2013;20(4):370–6. DOI: 10.1177/1553350612458544Gentile P., Di Pasquali C., Bocchini I. et al. Breast reconstruction with autologous fat graft mixed with platelet-rich plasma. Surg Innov 2013;20(4):370–6. DOI: 10.1177/1553350612458544Spartalis E.D., Tomos P., Dimitroulis D., Kouraklis G. Platelet-rich plasma in surgical oncology. Surg Innov 2014;21(4):441. DOI: 10.1177/1553350613520516Spartalis E.D., Tomos P., Dimitroulis D., Kouraklis G. Platelet-rich plasma in surgical oncology. Surg Innov 2014;21(4):441. DOI: 10.1177/1553350613520516Spartalis E.D., Tomos P., Konofaos P. et al. Breast reconstruction with autologous fat graft; does platelet-rich plasma affect patient’s survival? Int J Clin Exp Med 2014;7(1):329–30. PMID: 24482728.Spartalis E.D., Tomos P., Konofaos P. et al. Breast reconstruction with autologous fat graft; does platelet-rich plasma affect patient’s survival? Int J Clin Exp Med 2014;7(1):329–30. PMID: 24482728.Guo X., Wu Y., Hathaway H.J., Hartley R.S. Microenvironmental control of the breast cancer cell cycle. Anat Rec (Hoboken) 2012;295(4):553–62. DOI: 10.1002/ar.22417Guo X., Wu Y., Hathaway H.J., Hartley R.S. Microenvironmental control of the breast cancer cell cycle. Anat Rec (Hoboken) 2012;295(4):553–62. DOI: 10.1002/ar.22417Levva S., Kotoula V., Kostopoulos I. et al. Prognostic evaluation of epidermal growth factor receptor (EGFR) genotype and phenotype parameters in triple-negative breast cancers. Cancer Genomics Proteomics 2017;14(3):181–95. DOI: 10.21873/cgp.20030Levva S., Kotoula V., Kostopoulos I. et al. Prognostic evaluation of epidermal growth factor receptor (EGFR) genotype and phenotype parameters in triple-negative breast cancers. Cancer Genomics Proteomics 2017;14(3):181–95. DOI: 10.21873/cgp.20030Spartalis E., Tsilimigras D.I., Charalampoudis P. et al. The “Yin and Yang” of platelet-rich plasma in breast reconstruction after mastectomy or lumpectomy for breast cancer. Anticancer Res 2017;37(12):6557–62. DOI: 10.1016/j.gene.2019.04.025Spartalis E., Tsilimigras D.I., Charalampoudis P. et al. The “Yin and Yang” of platelet-rich plasma in breast reconstruction after mastectomy or lumpectomy for breast cancer. Anticancer Res 2017;37(12):6557–62. DOI: 10.1016/j.gene.2019.04.025Luzo A.C.M., Fávaro WJ, Seabra AB, Durán N. What is the potential use of platelet-rich-plasma (PRP) in cancer treatment? A mini review. Heliyon 2020;6(3):e03660. DOI: 10.1016/j.heliyon.2020.e03660Luzo A.C.M., Fávaro WJ, Seabra AB, Durán N. What is the potential use of platelet-rich-plasma (PRP) in cancer treatment? A mini review. Heliyon 2020;6(3):e03660. DOI: 10.1016/j.heliyon.2020.e03660Eichler C., Baucks C., Üner J. et al. Platelet-rich plasma (PRP) in breast cancer patients: an application analysis of 163 sentinel lymph node biopsies. Biomed Res Int 2020;2020:3432987. DOI: 10.1155/2020/3432987Eichler C., Baucks C., Üner J. et al. Platelet-rich plasma (PRP) in breast cancer patients: an application analysis of 163 sentinel lymph node biopsies. Biomed Res Int 2020;2020:3432987. DOI: 10.1155/2020/3432987Haahr M.K., Harken C., Toyserkani N.M. et al. A 12-month follow-up after a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label phase I clinical trial. Urology 2018;121:203.e6–203.e13. DOI: 10.1016/j.urology.2018.06.018Haahr M.K., Harken C., Toyserkani N.M. et al. A 12-month follow-up after a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label phase I clinical trial. Urology 2018;121:203.e6–203.e13. DOI: 10.1016/j.urology.2018.06.018Ding X.G., Li S.W., Zheng X.M. et al. The effect of platelet-rich plasma on cavernous nerve regeneration in a rat model. Asian J Androl 2009;11(2):215–21. DOI: 10.1038/aja.2008.37Ding X.G., Li S.W., Zheng X.M. et al. The effect of platelet-rich plasma on cavernous nerve regeneration in a rat model. Asian J Androl 2009;11(2):215–21. DOI: 10.1038/aja.2008.37Wu C.C., Wu Y.N., Ho H.O. et al. The neuroprotective effect of platelet-rich plasma on erectile function in bilateral cavernous nerve injury rat model. J Sex Med 2012;9(11):2838–48. DOI: 10.1111/j.1743-6109.2012.02881.xWu C.C., Wu Y.N., Ho H.O. et al. The neuroprotective effect of platelet-rich plasma on erectile function in bilateral cavernous nerve injury rat model. J Sex Med 2012;9(11):2838–48. DOI: 10.1111/j.1743-6109.2012.02881.xWu Y.N., Wu C.C., Sheu M.T. et al. Optimization of platelet-rich plasma and its effects on the recovery of erectile function after bilateral cavernous nerve injury in a rat model. J Tissue Eng Regen Med 2016;10(10):E294–E304. DOI: 10.1002/term.1806Wu Y.N., Wu C.C., Sheu M.T. et al. Optimization of platelet-rich plasma and its effects on the recovery of erectile function after bilateral cavernous nerve injury in a rat model. J Tissue Eng Regen Med 2016;10(10):E294–E304. DOI: 10.1002/term.1806Wu Y.N., Liao C.H., Chen K.C., Chiang H.S. Dual effect of chitosan activated platelet rich plasma (cPRP) improved erectile function after cavernous nerve injury. J Formos Med Assoc 2022;121(1 Pt 1):14–24. DOI: 10.1016/j.jfma.2021.01.019Wu Y.N., Liao C.H., Chen K.C., Chiang H.S. Dual effect of chitosan activated platelet rich plasma (cPRP) improved erectile function after cavernous nerve injury. J Formos Med Assoc 2022;121(1 Pt 1):14–24. DOI: 10.1016/j.jfma.2021.01.019Gettman M. A Study evaluating intraoperative application of platelet-rich plasma to the neurovascular bundles during nervesparing radical prostatectomy: initial technical description and prospective early postoperative outcomes analysis. Available at: https://clinicaltrials.gov/ct2/show/NCT02957149Gettman M. A Study evaluating intraoperative application of platelet-rich plasma to the neurovascular bundles during nervesparing radical prostatectomy: initial technical description and prospective early postoperative outcomes analysis. Available at: https://clinicaltrials.gov/ct2/show/NCT02957149Porst H. Review of the current status of low intensity extracorporeal shockwave therapy (Li-ESWT) in erectile dysfunction (ED), Peyronie’s disease (PD), and sexual rehabilitation after radical prostatectomy with special focus on technical aspects of the different marketed ESWT devices including personal experiences in 350 patients. Sex Med Rev 2021;9(1):93–122. DOI: 10.1016/j.sxmr.2020.01.006Porst H. Review of the current status of low intensity extracorporeal shockwave therapy (Li-ESWT) in erectile dysfunction (ED), Peyronie’s disease (PD), and sexual rehabilitation after radical prostatectomy with special focus on technical aspects of the different marketed ESWT devices including personal experiences in 350 patients. Sex Med Rev 2021;9(1):93–122. DOI: 10.1016/j.sxmr.2020.01.006Frey A., Sønksen J., Fode M. Low-intensity extracorporeal shockwave therapy in the treatment of postprostatectomy erectile dysfunction: a pilot study. Scand J Urol 2016;50(2):123–7. DOI: 10.3109/21681805.2015.1100675Frey A., Sønksen J., Fode M. Low-intensity extracorporeal shockwave therapy in the treatment of postprostatectomy erectile dysfunction: a pilot study. Scand J Urol 2016;50(2):123–7. DOI: 10.3109/21681805.2015.1100675Zewin T.S., El-Assmy A., Harraz A.M. et al. Efficacy and safety of low-intensity shock wave therapy in penile rehabilitation post nerve-sparing radical cystoprostatectomy: a randomized controlled trial. Int Urol Nephrol 2018;50(11):2007–14. DOI: 10.1007/s11255-018-1987-6Zewin T.S., El-Assmy A., Harraz A.M. et al. Efficacy and safety of low-intensity shock wave therapy in penile rehabilitation post nerve-sparing radical cystoprostatectomy: a randomized controlled trial. Int Urol Nephrol 2018;50(11):2007–14. DOI: 10.1007/s11255-018-1987-6Baccaglini W., Pazeto C.L., Corrêa Barros E.A. et al. The role of the low-intensity extracorporeal shockwave therapy on penile rehabilitation after radical prostatectomy: a randomized clinical trial. J Sex Med 2020;17(4):688–94. DOI: 10.1016/j.jsxm.2019.12.024Baccaglini W., Pazeto C.L., Corrêa Barros E.A. et al. The role of the low-intensity extracorporeal shockwave therapy on penile rehabilitation after radical prostatectomy: a randomized clinical trial. J Sex Med 2020;17(4):688–94. DOI: 10.1016/j.jsxm.2019.12.024Епифанова М.В., Каприн А.Д., Костин А.А. и др. Способ лечения эректильной дисфункции у пациентов, перенесших радикальную простатэктомию или брахитерапию. Патент на изобретение RU 2 741 204 C2, 22.01.2021. Бюлл. № 16 от 04.06.2020.Epifanova M.V., Kaprin A.D., Kostin A.A. et al. Method of treating erectile dysfunction in patients suffering radical prostatectomy or brachytherapy. Patent for invention RU 2 741 204 C2, 22.01.2021. Bull. No.16 dated 04.06.2022. (In Russ.).

The authors declare that there are no conflicts of interest present.